Editas Medicine Reports Q3 2026 Results: EPS of -$0.15 Misses Estimates, Revenue of $10. ...
Revenue of $10.4 Million Tops Consensus, Cash Runway Extended Into Second Half of 2028 Related Stocks: EDIT ,
Revenue of $10.4 Million Tops Consensus, Cash Runway Extended Into Second Half of 2028 Related Stocks: EDIT ,